Th22 cells increase in poor prognosis multiple myeloma and promote tumor cell growth and survival

There is increased production of plasmacytoid dendritic cells (pDCs) in the bone marrow (BM) of multiple myeloma (MM) patients and these favor Th22 cell differentiation. Here, we found that the frequency of interleukin (IL)-22(+)IL-17(−)IL-13(+) T cells is significantly increased in peripheral blood...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Oncoimmunology
Auteurs principaux: Di Lullo, Giulia, Marcatti, Magda, Heltai, Silvia, Brunetto, Emanuela, Tresoldi, Cristina, Bondanza, Attilio, Bonini, Chiara, Ponzoni, Maurilio, Tonon, Giovanni, Ciceri, Fabio, Bordignon, Claudio, Protti, Maria Pia
Format: Artigo
Langue:Inglês
Publié: Taylor & Francis 2015
Sujets:
Original Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4485827/
https://ncbi.nlm.nih.gov/pubmed/26155400
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2015.1005460
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires